Determining the Mechanisms of Loss of CAR T Cell Persistence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Determining the Mechanisms of Loss of CAR T Cell Persistence — Stella

Home/Acute Lymphoblastic Leukemia With Failed Remission/

View on ClinicalTrials.gov

Recruiting

Back to Acute Lymphoblastic Leukemia With Failed Remission trials

Trial locations(3 sites)

United Kingdom

Great Ormond Street Hospital, London

University College London Hospital, London

Royal Manchester Children's Hospital, Manchester

Key details

Sponsor

University College, London

Enrollment target

~50 participants

Started

October 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.